XML 83 R5.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Preferred Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Income
2020 Financing
2020 Financing
Common Stock
2020 Financing
Preferred Stock
2020 Financing
Additional Paid-in Capital
Beginning balance (in shares) at Dec. 31, 2018   16,642   0              
Beginning balance at Dec. 31, 2018 $ 168,521 $ 17   $ 0 $ 676,572 $ (509,406) $ 1,338        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Stock-based compensation 2,981       2,981            
Exercise of stock options and warrants (in shares)   12                  
Exchange of shares for Series B Warrants 236       236            
Award of restricted stock units (in shares)   47                  
Award of restricted stock units 1       1            
Return of common stock to pay withholding taxes on restricted stock (in shares)       15              
Return of common stock to pay withholding taxes on restricted stock (499)       (499)            
Cancellation of treasury stock (in shares)       (15)              
Cumulative effect of change in accounting principle 0       (7) 7          
Other comprehensive (loss) income (1,949)           (1,949)        
Net loss (22,525)         (22,525)          
Ending balance (in shares) at Mar. 31, 2019   16,701   0              
Ending balance at Mar. 31, 2019 146,766 $ 17   $ 0 679,284 (531,924) (611)        
Beginning balance (in shares) at Dec. 31, 2019   20,691 0 0              
Beginning balance at Dec. 31, 2019 55,535 $ 21 $ 0 $ 0 720,484 (663,600) (1,370)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Stock-based compensation 1,923       1,923            
Issuance of common and preferred stock, net of issuance costs (in shares)   7,030             14,122 7,937  
Issuance of common stock, net of issuance costs 11,212 $ 7     11,205     $ 13,525 $ 14 $ 79 $ 13,432
Conversion of preferred stock to common stock (in shares)   3,053 3,053                
Conversion of preferred stock to common stock 0 $ 3 $ 30   27            
Exercise of stock options and warrants (in shares)   2,041                  
Exchange of shares for Series B Warrants 2,470 $ 2     2,468            
Award of restricted stock units (in shares)   141                  
Award of restricted stock units 0                    
Return of common stock to pay withholding taxes on restricted stock (in shares)       28              
Return of common stock to pay withholding taxes on restricted stock (33)       (33)            
Cancellation of treasury stock (in shares)       (28)              
Other comprehensive (loss) income (872)           (872)        
Net loss (16,598)         (16,598)          
Ending balance (in shares) at Mar. 31, 2020   47,078 4,884 0              
Ending balance at Mar. 31, 2020 $ 67,162 $ 47 $ 49 $ 0 $ 749,506 $ (680,198) $ (2,242)